Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives

Author:

Liu Aifen1,Hu Jingyan1,Yeh Tzu-Shao12,Wang Chengniu1,Tang Jilong1,Huang Xiaohong1,Chen Bin1,Huangfu Liexiang1,Yu Weili1,Zhang Lei13

Affiliation:

1. Institute of Interdisciplinary Integrative Medicine Research, School of Medicine, Nantong University, Nantong 226001, China

2. Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong 226019, China

3. Department of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai 200433, China

Abstract

Abstract: Cerebral ischemic stroke is a disease with high prevalence and incidence. Its management focuses on rapid reperfusion with intravenous thrombolysis and endovascular thrombectomy. Both therapeutic strategies reduce disability, but the therapy time window is short, and the risk of bleeding is high. Natural products (NPs) have played a key role in drug discovery, especially for cancer and infectious diseases. However, they have made little progress in clinical translation and pose challenges to the treatment of stroke. Recently, with the investigation of precise mechanisms in cerebral ischemic stroke and the technological development of NP-based drug discovery, NPs are addressing these challenges and opening up new opportunities in cerebral stroke. Thus, in this review, we first summarize the structure and function of diverse NPs, including flavonoids, phenols, terpenes, lactones, quinones, alkaloids, and glycosides. Then we propose the comprehensive neuroprotective mechanism of NPs in cerebral ischemic stroke, which involves complex cascade processes of oxidative stress, mitochondrial damage, apoptosis or ferroptosis-related cell death, inflammatory response, and disruption of the blood-brain barrier (BBB). Overall, we stress the neuroprotective effect of NPs and their mechanism on cerebral ischemic stroke for a better understanding of the advances and perspective in NPs application that may provide a rationale for the development of innovative therapeutic regimens in ischemic stroke.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Nantong University undergraduate innovation training program

school-enterprise cooperation program

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine

Reference255 articles.

1. Tsao C.W.; Aday A.W.; Almarzooq Z.I.; Alonso A.; Beaton A.Z.; Bittencourt M.S.; Boehme A.K.; Buxton A.E.; Carson A.P.; Commodore-Mensah Y.; Elkind M.S.V.; Evenson K.R.; Eze-Nliam C.; Ferguson J.F.; Generoso G.; Ho J.E.; Kalani R.; Khan S.S.; Kissela B.M.; Knutson K.L.; Levine D.A.; Lewis T.T.; Liu J.; Loop M.S.; Ma J.; Mussolino M.E.; Navaneethan S.D.; Perak A.M.; Poudel R.; Rezk-Hanna M.; Roth G.A.; Schroeder E.B.; Shah S.H.; Thacker E.L.; VanWagner L.B.; Virani S.S.; Voecks J.H.; Wang N.Y.; Yaffe K.; Martin S.S.; Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation 2022,145(8),e153-e639

2. Iadecola C.; Anrather J.; Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 2011,14(11),1363-1368

3. Sacco R.L.; Kasner S.E.; Broderick J.P.; Caplan L.R.; Connors J.J.B.; Culebras A.; Elkind M.S.V.; George M.G.; Hamdan A.D.; Higashida R.T.; Hoh B.L.; Janis L.S.; Kase C.S.; Kleindorfer D.O.; Lee J.M.; Moseley M.E.; Peterson E.D.; Turan T.N.; Valderrama A.L.; Vinters H.V.; An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013,44(7),2064-2089

4. Campbell B.C.V.; De Silva D.A.; Macleod M.R.; Coutts S.B.; Schwamm L.H.; Davis S.M.; Donnan G.A.; Ischaemic stroke. Nat Rev Dis Primers 2019,5(1),70

5. Emberson J.; Lees K.R.; Lyden P.; Blackwell L.; Albers G.; Bluhmki E.; Brott T.; Cohen G.; Davis S.; Donnan G.; Grotta J.; Howard G.; Kaste M.; Koga M.; von Kummer R.; Lansberg M.; Lindley R.I.; Murray G.; Olivot J.M.; Parsons M.; Tilley B.; Toni D.; Toyoda K.; Wahlgren N.; Wardlaw J.; Whiteley W.; del Zoppo G.J.; Baigent C.; Sandercock P.; Hacke W.; Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014,384(9958),1929-1935

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3